Glycemic Index Laboratories, Inc.
Toronto, Ontario, M5C 2X3, Canada
NCT Number: NCT00801814
To determine palatability and extent to which escalating doses of a novel highly viscous polysaccharide [NVP] reduces postprandial glycemia when added to a liquid and a solid meal.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 2 / Phase 3
Toronto, Ontario, M5C 2X3, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2.5 grams of PGX
5.0 grams of PGX
7.5 grams of PGX
0g of PGX
0g of PGX
Time frame: Acute study measuring postprandial glucose levels over 2 hours
Time frame: Data analysis
Glycemic Index Laboratories, Inc
Industry
Effect of Adding Escalating Doses of a Novel Highly Viscous Polysaccharide to Either a Liquid or a Solid Test Meal on Post Prandial Glycemia in Healthy Subjects: Determination of the Glycemic Reduction Index Potential (GRIP)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01108328
Appetite and Hunger, Suppression, Blood Glucose, Postprandial
Coquitlam, British Columbia, Canada
View Trial DetailsNCT01580150
Blood Glucose, Postprandial, Blood Insulin, Postprandial
Kuopio, Finland
View Trial DetailsNCT00935350
Blood Glucose, Postprandial
Toronto, Ontario, Canada
View Trial Details